ABSTRACT -The purpose of this research was to investigate if Vitamin E could decrease the toxiceffects of endosulfan on erythrocyte immunity and its regulating mechanism. The levels of endosulfan and Vitamin E were (in mg/kg/d), respectively, 0 and 0 (control group), 0.8 and 0 (endosulfan-only group), 0.8 and 100 (experimental group). The results showed that Vitamin E inhibited endosulfan-induced decreases in rosette ratios of erythrocyte C 3 b receptor and increases in rosette ratios of erythrocyte immune complex. Vitamin E reversed the decline tendency of erythrocytes to regulate T-lymphocyte activity and the increase tendency of erythrocyte immunosuppressive factor activity in plasma induced by endosulfan. Further, Vitamin E alleviated the decreases of CD35 mRNA levels in spleen and CD35 expression on B-lymphocyte surfaces, antagonized a decline in Crry mRNA levels. Lastly, Vitamin E reversed induced decreases in total anti-oxidation capability and increases in malondi-aldehyde and free radical levels in spleen caused by endosulfan. The results suggested that Vitamin E relieved endosulfan-induced effects on erythrocytes immunity, reversed changes in expression of erythrocyte immune factors, and antagonized oxidative stress. Vitamin E could stabilize the expression of Crry receptor by inhibiting oxidative stress, and thereby reverse the decrease of erythrocyte immunity caused by endosulfan.
INTRODUCTION
Endosulfan, a chlorinated organic pesticide and acaricide, is being considered a persistent organic pollutant. Although endosulfan is banned or severely restricted in some countries, it is still widely used in many areas of the world, including China. Endosulfan can enhanced levels of lipid peroxidation in chicks (Aggarwal et al., 2008) ; and led to oxidative damage of DNA in rats (Zhu et al., 2002) . The effects of endosulfan on mammalian immune responses were increased at low endosulfan doses (Wade et al., 2002) but decreased with high doses (Abadin et al., 2007) . Endosulfan induced apoptosis in human lymphocytes in vitro (Jamil et al., 2004) ; led to significant depression in the proliferative abilities of chick peripheral blood/splenic lymphocytes in chicks (Aggarwal et al., 2008) .
Erythrocyte immune function was first found in mammals in the 1953 (Nelson et al., 1953) , and it was confirmed again in the 1981, and thereby the concept of "Red-cell immune system" was suggested by Siegel et al. (1981) . The primate erythrocytes play an important role in the protection against certain infectious diseases (Reinagel and Taylor, 2000) . β-Endorphine in low doses improved erythrocyte immune function, while in high dosage inhibited it in human (Sun et al., 1994) . Microdosis selenium improved the erythrocyte immune function in Trionyx sinensis (Liu et al., 2006) , while high dosage copper depressed complement receptor type 1 (CR1 or CD35) activity in young duck (Yang et al., 2007) . But little information is known about the mechanisms of endosulfan toxicity to erythrocyte immunity. Considering Vitamin E is an immunomodulator and an important anti-oxidant, and it can decrease the cardiotoxicity induced by endosulfan (Kalender et al., 2004) , depressed oxidative stress, regulated cytokines and lymphocyte subsets (Hsieh and Lin, 2005) . So the present study was designed to evaluate the effect of Vitamin E on erythrocyte immunity and its mechanism in mice exposure to endosulfan, so as to show whether Vitamin E alleviates or partly alleviates the immunotoxicity caused by endosulfan and its action mechanism.
MATERIALS AND METHODS

Animals
Pathogen-free male ICR mice (obtained from Vital River Laboratory Animal Technology Limited Corporation, Beijing, China) were used in the present study. Each mouse was raised in a standard cage (26 cm × 15 cm × 15 cm) and maintained in a facility with a constant temperature (22 ± 2°C) and humidity (50 ± 5%) with a 12:12-hr light/dark cycle. All mice were provided ad libitum access to filtered drinking water and mouse chow (nutritional ingredients: 20.6% protein, 4.16% fat, 53.17% carbohydrate, 4.92% crude fiber, 7.5% ash content, and 9.65% moisture content; Beijing Ke Ao Xieli Corporation, Ltd.). All mice were allowed to acclimate for 10 d prior to any use in a given experiment. All protocols here were approved by the animal experimentation committee.
Experimental design and methods
Endosulfan (96% purity) was provided by Jiangsu Kuai Da Nong Hua Limited Corp. (Rudong County, Jiangsu Province, China) . Vitamin E (95% purity) was obtained from Sigma (St. Louis, MO, USA). Corn oil was obtained from COFCO Food Sales & Distribution Co., Ltd. (Beijing, China) .
Mice (n = 24) with a body weight of 23.1-30.5 g were used in this study. Mice were randomly assigned into three groups (8/group) to then receive (by gavage) endosulfan and Vitamin E at, respectively, 0 and 0 mg/kg/d (Control), 0.8 and 0 mg/kg/d (endosulfan-only), or 0.8 and 100 mg/kg/d (experimental group). Endosulfan was dissolved in corn oil and admini-stered 2 hr prior to the Vitamin E. The mice in the control group received an equal volume of corn oil. After 3 weeks of daily gavages, the mice were euthanized by intraperitoneal injection of 400 mg/kg chloral hydrate (Beijing Xuanwu Hospital, Beijing, China). At necropsy, blood samples were collected from eyes and the spleens of all mice were isolated.
Preparation of blood samples
Blood samples were divided into two parts, one part inactivated at 58°C for 30 min and the other parts were left at room temperature. Lymphocytes were separated by the lymphocyte separation medium which was obtained from Tianjin Hao Yang Biological Manufacture CO., LTD (Tianjin, China). The lymphocytes were suspended in the Dulbecco's modification of Eagle's medium Dulbecco (DMEM) (obtained from HyClone Co., Ltd., Logan, UT, USA) with 10% fetal bovine serum (FBS) (HyClone) at a concentration of approximately 1 × 10 8 cells per ml. The underlying erythrocytes were suspended in a 0.9% NaCl solution at a concentration of approximately 1.25 × 10 7 cells per ml.
Preparation of liquid yeast
Novelty yeasts obtained from Angel Yeast Co., Ltd. (Shenzhen, China) and dissolved in a 0.9% NaCl solution, inactivated at high temperature (100°C), filtered and then divided into two parts. To prepare sensitized yeast, an equal amount of serum from naïve mice was combined with one part of the yeast mixture. The mixture was incubated at 37°C for 15 min, and then washed with 0.9 % NaCl solution by centrifugation at 2,500 r/min for 10 min. The other portion of the stock yeast was prepared as above but without the addition of serum (i.e., the nonsensitized yeast). Each yeast preparation was ultimately resuspended in a 0.9% NaCl solution at 1 ×10 8 yeast/ml.
Determination of abilities of erythrocyte immune adherence
Erythrocyte C3b receptor (E-C3bR) rosette ratios were determined using the method described by Zhang et al. (2012) . Briefly, 50 μl of sensitized yeast suspension and 50 μl of erythrocyte suspension were mixed and incubated at 30°C for 30 min. Thereafter, 100 μl 0.9 % NaCl solution and 25 μl 0.25% glutaraldehyde were added. Smears were then prepared on microscope slides, fixed with methanol, dyed with Wright's stain, washed with PBS. Two hundred erythrocytes were counted per smear under a microscope; two replicates/mouse were examined. An erythrocyte bound to one or more yeast cells was considered a rosette. E-C 3 bR rosette ratios were calculated as E-C 3 bR (%) = 100% × (N1/200), where N1 represents the number of erythrocytes binding one or more sensitized yeast cells. Erythrocyte immune complex (E-IC) rosette ratios were determined as above except that the yeast was not pre-sensitized with mouse serum. E-IC rosette ratios were calculated as E-IC (%) = 100% × (N2/200), where N2 represents the number of erythrocytes binding one or more non-sensitized yeast cells.
Assay of erythrocyte promoting T-lymphocyte activity
The activity of erythrocyte promoting T-cell was determined according to the method of Guo et al. (1988) . Briefly, after trypsinization, HeLa cells were suspended in normal saline solution, an equal volume of naïve mouse serum was added, and the mixture then incubated at 37°C for 30 min. Thereafter, the cells (now, sensitized HeLa) were washed with normal saline. Isolated lymphocytes from mice were suspended in normal saline at ≈ 10 7 cells/ml and erythrocytes were suspended in normal saline at a ≈ 10 8 cells/ml. An aliquot (50 μl) of sensitized HeLa cells, 25 μl red blood cells (RBC) in the experimental group; and 50 μl sensitized HeLa cells, 0.9% NaCl 25 μl in the control group, was then added. Then incubated at 37°C for 30 min, added 50 μl lymphocytes, mixed and incubated at 37°C for 1 hr, then stored at 4°C for the night. 25 μl 0.25% glutaraldehyde were added. Then smears of the mixture were prepared on microscope slices, and then fixed with methanol, dyed with Wright stain, and then washed with PBS, followed with tap water, and dried. One hundred HeLa cells were counted per smear under microscope, and two replicates were used per animal. A HeLa cell that bound ≥1 lymphocyte was considered a rosette. The rosette ratios of erythrocyte promoting T-cell activity were estimated using the following formula: the rosette ratios of erythrocyte promoting T-cell activity = (the rosette ratios of experimental group -the rosette ratios of control group)/the rosette ratios of control group × 100%.
Assay of erythrocyte promoting natural-killer cell activity
The ability of the erythrocytes to promote natural killer cell (NK) activity was examined using the method described by Zhang et al. (2012) . Briefly, HeLa cells were suspended in DMEM containing 10% FBS at 10 6 cells/ml and lymphocytes were suspended at the concentrations described above. A mixture of 6 μl HeLa cells, 12 μl mononuclear cells, 3 μl RBC, and 9 μl DMEM containing 10% FBS comprised the experimental group; 6 μl HeLa cells, 3 μl RBC, and 21 μl DMEM containing 10% FBS comprised the natural release group; and 15 μl 2.5% Triton, 6 μl HeLa cells, 3 μl RBC, and 6 μl DMEM containing 10% FBS composed the maximum release group.
The mixtures were incubated at 37°C for 18 hr, then centrifuged. The resultant supernatant was recovered and diluted 10-fold with distilled water. Lactate dehydro -genase (LDH) activity was then determined using a commercial kit (Biosino Biotechnology and Science Inc., Beijing, China) and an automatic biochemistry analyzer (EOS-bravo Forte). NK activity was calculated (based on LDH activities) as NK activity (%) = 100% × (experimental release group LDH activity -natural release group LDH activity)/(maximum release group LDH activitynatural release group LDH activity).
Assays of innate immune enhancing factor and immunosuppressive factor activities
The assays of innate immune enhancing factor and immunosuppressive factor activities were carried out methods described by Zhang et al. (2012) . Briefly, 75 μl 0.9% NaCl solution (NS) and 50 μl of RBC suspension were mixed with 75 μl inactivated plasma or 75 μl activated plasma. Yeast suspension sensitized by C 3 b (50 μl) was then added, and the mixtures were incubated at 37°C for 30 min. Then 125 μl NS and 50 μl glutaraldehyde were added. Smears of each mixture were then prepared. Slides were fixed with formaldehyde, dyed with Wright's stain, and erythrocytes (200/smear) were counted using a microscope. An erythrocyte bound to ≥ 1 yeast cell was considered a rosette. The erythrocyte C 3 b receptor rosette-forming enhancing rate (RFER) represented immune enhancing factor activity; the erythrocyte C 3 b receptor rosette-forming inhibitory rate (RFIR) represented immunosuppressive factor activity. RFER was calculated as 100 x (rosette rate of E-C 3 bR in inactivated plasma group -rate of E-C 3 bR in NS group)/(rate of E-C 3 bR in NS group). RFIR was calculated as 100 × (rosette rate of E-C 3 bR in inactivated plasma group -rate of E-C 3 bR in plasma group at room tempera-ture)/(rate of E-C 3 bR in inactivated plasma group).
RNA extraction
Total RNA was extracted from each sample according to the Trizol Reagent protocol (Invitrogen, Carlsbad, CA, USA). RNA was quantified and characterized for purity by UV spectrophotometric analysis at A260 and A260/ A280 ratio, respectively. The quality of RNA was tested using agarose gel electrophoresis to detect 28S and 18S RNA subunits under a UV transilluminator.
cDNA synthesis
The target RNA (1 μg) was reverse transcribed using the Super RT Kit and cDNA First Strand cDNA Synthesis Kit (BioTeke Corporation, Beijing, China) according to the instructions provided by the manufacturers. The reverse transcription reaction solution was prepared with a 20 μl final volume consisted of the following: 1 μg total RNA, 1 μl 50 μmol/l Oligo dT Primer, 1 μl5 × first-strand Buffer, 1 μl 200 U/μl M-MuLV RTase, 1 μl 40 U/μl RNase Inhibitor were added into the PCR tube on ice. The cDNA was obtained by reverse transcription reaction occurred under the following conditions: 30°C for 10 min, 42°C for 60 min, and 95°C for 5 min.
Primers
The cDNA sequences for mouse CD35, CD59, Crry, and H factor were retrieved from GenBank (http://www. ncbi.nlm.nih.gov/genbank). Primers were designed using the Primer 5 software (Premier Biosoft International Company, CA, USA). Basic Local Alignment Search Tool (BLAST) was used to confirm the gene specificity of the primers. All primer sets were designed for optimal PCR efficiency and to avoid secondary structure and primer dimers; primers were synthesized by Shanghai Sangon Biosystems (Shanghai, China). Amplification lengths were set between 120 and 200 bp. Sequences of specific primers were:
Crry-R 5-AAGGATACCGCCTCATTGGTTCCTC-3 H factor-F 5-GCCTCCTCCACCTATTGACA-3 H factor-R 5-GTACGAAATGGCGGTGAATC-3 β-actin-F: 5-AGAGGGAAATCGTGCGTGAC-3 β-actin-R: 5-CAATAGTGATGACCTGGCCGT-3
Quantitation of gene transcription in erythrocyte immune correlation factors with real-time PCR
Concentrations of immune correlation factor cDNA templates were quantified using real-time triplex PCR using a 2 × SYBR real-time PCR Premixture (Bioteke Corporation, Beijing, China) with an Mx3000P QPCR system (Stratagene Company, La Jolla, CA, USA). PCR amplifications were performed in a 20 μl volume containing: 1 μl cDNA, 0.4 μl of each primer (100 nmol/l), 10 μl 2X SYBR real-time PCR Premixture (BioTeke), and 8.2 μl of sterile nuclease-free water. Each PCR amplification was performed in triplicate under the conditions: 95°C for 10 min for initial denaturation, amplification for 40 cycles (95°C for 30 sec [denaturation], 60°C for 1 min [annealing] , and 72°C for 30 sec [extension]). To confirm the PCR product and cycle of melting curve analysis, conditions of 95°C for 1 min, 60°C for 30 sec, and 95°C for 30 sec were used. All data were analyzed with MxPro QPCR software (Version 3.0, M × 3000P system, Stratagene). Relative expression of mRNA was analyzed via the formula (RQ=2 −ΔΔCT ) (Livak et al., 2001) .
Determination of CD59 protein expression on erythrocyte membrane
The protein expressions of CD59 on erythrocyte membrane surface were determined according to the method described by Guo et al. (1988) . 1 μl anticoagulated blood was washed twice using PBS, and then the blood cells were mixed with 100 μl PBS, and added 1 μl CD59 monoclonal antibody of mouse-antimouse (Obtained from American abCam company, Plymouth, MA, USA), and then incubated at room temperature for 20 min. Homeotype control group did not be added first antibody. The mixture was washed twice using PBS, and then those cells was suspended using 100 μl PBS, and added 8 μl fluorescence second antibody of sheep-anti mouse IgG-FITC (purchased from Beijing Xin Jing Ke Biotechnology Limited Company, Beijing, China), and then incubated away from light for 20 min. The mixture was washed twice using PBS, and added 200 μl PBS to suspend those cells again. The cell suspension was filtered using 300 screen mesh nylon membrane, and then determined using flow cytometer, the mean fluorecence intensity of CD59 was calculated.
Determinations of CD35 protein expression
The determinations of CD35 protein expression on leucocyte membrane surface were determined according to the method described by Guo et al. (1988) . Briefly, 1 μl anticoagulated blood was mixed with 300 μl blood cell lysate. Then centrifugalized to precipitate lymphocyte. Then 200 μl blood cell lysate was added into the leukocyte precipitate, centrifugalized. Then 3 ml PBS was mixed with the leukocyte precipitate to wash twice, and added 100 μl PBS. 2 μl monoclonal antibody of rat-anti-mouse (American BD company produced, Franklin Lakes, NJ, USA) was added into 100 μl leukocyte suspension, incubated at room temperature for 20 min. Homeotype control group did not be added first antibody. The mixture was washed twice using PBS, and then those cells was suspended using 100 μl PBS, and added 8 μl fluorescence second antibody of sheep-anti rat IgG-FITC (purchased from Beijing Xin Jing Ke Biotechnology Limited Company, Beijing, China), and then incubated away from light for 20 min. The mixture was washed twice using PBS, and added 200 μl PBS to suspend those cells again. The cell suspension was filtered using 300 screen mesh nylon membrane, and then determined using flow cytometer, the mean fluorecence intensity of CD35 was calculated.
The protein expressions of CD35 on erythrocyte membrane surface were determined according to the method described by Guo et al. (1988) . 1 μl anticoagulated blood was washed twice using PBS, and then the blood cells were mixed with 100 μl PBS for suspension. The following procedures after blood cells were suspended were the same as CD35 on leucocyte membrane surface.
Determinations of CD58 protein expression on erythrocyte membrane surface
The membrane protein of erythrocyte surface was extracted according to the method described by Xiao and Yang (1997) . Briefly, 0.2 ml blood was mixed with 1 ml Tris-HCl, incubated at 4°C for 2 hr, and then centrifugalizd, removed supernatant. The above procedure was duplicated until there was no red blood cell observed by naked eye. The sediment was added into PBS, and stored at -20°C. The following procedures were in accordance with description of enzyme-linked immunosorbent assay kit (ELISA kit) of lymphocyte function associated antigen-3 in mouse. The OD value was determined using enzyme-labeled instrument (Multiskan Ascent) at 450 nm.
Determinations of total anti-oxidation capability, malondialdehyde and hydroxyl free radicals
Spleen homogenate were prepared with normal saline on ice according to the instructions provided by the Nanjing Jian Cheng Bioengineering Institute (Nanjing, China). The protein concentrations of spleen homogenates were assayed with a Coomassie (Bradford) Protein Assay Kit. The contents of total anti-oxidation capability (T-AOC), malondialdehyde (MDA) and hydroxyl free radical were determined using a Multiskan Ascent microplate reader (Thermolabystems company, Holland) at 520 nm, 532 nm and 550 nm, respectively.
Statistical analysis
All data were analyzed with SPSS 16.0, a statistical software package. The significance of differences between control and endosulfan-treated groups, and endosulfantreated and experimental groups were determined using a t-test, respectively. All values were expressed as the mean ± S.E. The results were considered significant at P < 0.05 (* = p < 0.05, ** = p < 0.01 and ***p = < 0.001.).
RESULTS
Changes in E-C 3 bR and E-IC rosette ratios
To study the changes in E-C3bR and E-IC rosette ratios between endosulfan-treated group and the control group, we carry out the experiment. The result showed that endosulfan caused a significant change in the levels of of E-C 3 bR rosette ratios in mice (t = -3.241, P = 0.004). The rosette ratios of E-C 3 bR in the endosulfantreated group significantly reduced when compared with the control group (P < 0.01). While Vitamin E had significantly reversed the rosette ratios of E-C 3 bR in the endosulfan-treated group (t = -7.962, P = 0.000). The rosette ratios of E-C 3 bR in the experimental group were higher than that of the endosulfan-treated group (P < 0.001; Fig. 1A) .
The rosette ratios of E-IC in the endosulfan-treated group significantly increased when compared with the control group (t = -8.532, P = 0.000). While Vitamin E had a significant the rosette ratios of E-IC in the endosulfan-treated mice (t = 3.956, P = 0.001). The rosette ratios of E-IC in the experimental group were lower than that of the endosulfan-treated group (P < 0.05; Fig. 1B) . Changes of erythrocyte promoting natural killer (NK) cell activity and regulating T lymphocyte immune adherence activity in mice To study the changes of erythrocyte promoting NK cell activity and regulating T lymphocyte immune adherence activity among endosulfan-treated group, Vitamin E group and the control group, we carry out the experiment. The result showed that endosulfan and Vitamin E had no significant influence on the activity of erythrocyte promoting NK (t = -0.743, P = 0.472). The activity of erythrocyte promoting NK had no noticeable difference bewteen endosufan-treated group and control group (P > 0.05). There was also no significant difference bewteen endosufan-treated group and experimental group (P > 0.05 ; Fig. 2A ).
Endosulfan had no significant effect on the activity of erythrocyte regulating T lymphocyte immune adherence (t = 1.987, P = 0.078). Although the activity of erythrocyte regulating T lymphocyte immune adherence in endosufan-treated group had a decrease tendency, there was no significant difference compared to control group (P > 0.05). Vitamin E had a significant effect on the activity of erythrocyte regulating T lymphocyte immune adherence in endosulfan-treated mice (t = -2.760, P = 0.017), and the activity of erythrocyte regulating T lymphocyte immune adherence in experimental group was significantly higher than that of the endosulfan-treaded group (P < 0.05 ; Fig. 2B )
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The activity of T-lymphocyte (%) Fig. 2 . Effects of vitamin E on the activities of erythrocyte immune correlation factors in endosulfan-treated mice (Mean ± S.E). Asterisks represents significant differences (* = p < 0.05, ** = p < 0.01 and *** = p < 0.001). A: The changes of erythrocyte promoting NK activities; B: The changes of erythrocyte regulating T lymphocyte adherence activities; C: The changes of erythrocyte immune enhancing factor activities in plasm; D: The changes of erythrocyte immunosuppressive factor activities in plasm.
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Vol. 37 No. 6 Changes in activities in erythrocyte innate immune enhancing and immunosuppressive factor in plasma To study the changes in activities in erythrocyte innate immune enhancing and immunosuppressive factor in plasma among endosulfan-treated group, Vitamin E group and the control group, we carry out the experiment. The result showed that endosulfan had significant effects on the activities of erythrocyte innate immune enhancing factor of plasma in mice (t = 7.259, P = 0.000). The activity of erythrocyte innate immune enhancing factor in endosulfan-treated group was significantly lower than that of control group (P < 0.001). Vitamin E had significant effects on the activities of erythrocyte innate immune enhancing factor of plasma in mice (t = -6.506, P = 0.000). The activities of erythrocyte innate immune enhancing factor in experimental group were significantly higher than that of endosulfan-treated group (P < 0.001) (Fig. 2C) .
Although the activities of erythrocyte immunosuppressive factor of plasma in endosulfan-treated group had an increase tendency compared to control group, there was no significant difference between two groups (t = -1.650, P = 0.116). While the activities of erythrocyte immunosuppressive factor in experimental group was obviously lower than that of endosulfan-treated group (t = 3.903, P = 0.001) (Fig. 2D) .
The gene transcription changes of immune correlation receptors in spleen
To study the changes of immune correlation receptors (CD59, CD58, CD35, H factors Crry) mRNA in spleen among endosulfan-treated group, Vitamin E group and the control group, we carry out the experiment. t-test showed that both endosulfan and Vitamin E had no significant effects on the CD59 mRNA levels (t = 0.064, P = 0.950; t = -0.380, P = 0.712). There was no significant difference between control group and endosulfan group as well as between endosulfan group and experiment group (P > 0.05) (Fig. 3A) .
Endosalfan obviously inhibited the CD35 mRNA levels of spleen (t = 4.021, P = 0.010), and the CD35 mRNA levels in endosulfan group were significantly lower than those of control group (P < 0.05). While the CD35 mRNA levels of spleen in experimental group were significantly higher than those of endosulfan group (P < 0.01) (Fig. 3B) .
Endosulfan obviously affected the mRNA levels of H factors in spleen (t = 3.384, P = 0.005), and the mRNA levels of H factors in endosulfan group significantly decreased compared with control group (P < 0.01). Vitamin E had no obvious effects on the mRNA levels of H factors (t = -0.972, P = 0.342), and there was no significant difference between endosulfan group and experimental group (P > 0.05) (Fig. 3C) .
Endosulfan obviously decreased the Crry mRNA levels in spleen (t = 3.420, P = 0.013), and the Crry mRNA levels in endosanfan group significantly declined compared with control group (P < 0.05). While Vitamin E had obvious effects on the Crry mRNA levels of spleen in endosulfantreated mice (t = -10.52, P = 0.000), the Crry mRNA levels of spleen in experimental group significantly increased compared with endosulfan group (P < 0.001) (Fig. 3D) .
The gene expression changes of immune correlation factor of whole blood cell (erythrocyte and B lymphocyte)
To study the gene expression changes of immune correlation factor of whole blood cell (erythrocyte and B lymphocyte) among endosulfan-treated group, Vitamin E group and the control group, we carry out the experiment. t-test showed that both endosulfan and Vitamin E had no significant effects on the protein expression of CD59 on erythrocyte membrane surface in mice (t = 1.639, P = 0.1290), and there were no obvious differences between control group and endosalfan group as well as between endosalfan group and experimental group (P > 0.05) (Fig. 4A) .
CD35 had no protein expression on erythrocyte menbrance surface in all three groups. But endosulfan significantly influenced the protein expression levels of CD35 on B lymphocyte menbrance surface (t = 2.468, P = 0.033), and the protein expression levels of CD35 on B lymphocyte menbrance in endosulfan group obviously decreased control group (P < 0.05). Vitamin E had significant effects on the protein expression levels of CD35 on B lymphocyte menbrance in endosulfan-treated mice (t = -2.961, P = 0.028), and the protein expression levels of CD35 in experimental group obviously increased compared with endosulfan group (P < 0.05) (Fig. 4B) .
Both Endosulfan and Vitamin E had no obvious effect on the protein expression levels of CD58 on the erythrocyte membrane surface (t = -0.266, p = 0.055; t = -0.713, p = 0.486) and there were no significant difference between control group and endosulfan group as well as between endosulfan group and experimental group (P > 0.05) (Fig. 4C) 
The changes of oxidative stress in spleen
To study the changes of oxidative stress in spleen among endosulfan-treated group, Vitamin E group and the control group, we carry out the experiment. The result showed that endosulfan had obvious effects on Vol. 37 No. 6 total anti-oxidation capability (T-AOC) of spleen in mice (t = 3.341, P = 0.013), and the T-AOC in endosulfan group significantly decreased compared with control group (P < 0.05). Vitamin E obviously affected the T-AOC of spleen in endosulfan-treated mice (t = -2.769, P = 0.020), and the T-AOC in experimental group was obviously higher than that of endosulfan group (P < 0.05) (Fig. 5A) .
Endosulfan significantly increased the malondialdehyde (MDA) levels of spleen in mice (t = -3.883, P = 0.003), and the MDA level of spleen in endosulfan group was obviously higher than that of control group (P < 0.05). Vitamin E obviously affected the MDA levels of spleen in endosulfan-treated mice (t = 3.164, P = 0.01), and the MDA level in experimental group significantly decreased compared with endosulfan group (P < 0.05) (Fig. 5B) .
Endosulfan significantly influenced the levels of hydroxyl free radical of spleen in mice (t = -4.782, P = 0.001), and the level of hydroxyl free radical of spleen in endosulfan group significantly increased compared with control group (P < 0.05). Vitamin E obviously affected the levels of hydroxyl free radical of spleen in endosulfan-treated mice (t = 5.701, P = 0.000), and the level of hydroxyl free radical of spleen in experimental group was significantly lower than that of endosulfan group (P < 0.05) (Fig. 5C ).
Control
Experimental group
Relative level of Crry mRNA Fig. 3 . Effects of vitamin E on the mRNA levels of immune correlation receptors of spleen in endosulfan-treated mice (Mean ± S.E.). Asterisks represents significant differences (* = p < 0.05, ** = p < 0.01 and *** = p < 0.001). A: The changes of CD59 mRNA levels; B: The changes of CD35 mRNA levels; C: The changes of H factor mRNA levels; D: The changes of Crry mRNA levels. 
DISCUSSION
The effects of endosulfan on the immune adherence activity of erythrocyte and its immune correlation factor in mice CR1 on the erythrocyte membrane played an important role in immune adherence activity of erythrocyte in primate (Kalli et al., 1991) . The rosette rates of E-C 3 bR and E-IC were previously demonstrated to represent the activity of CR1 (Birmingham and Hebert, 2001) . That both the rosette ratios of E-C 3 bR and E-IC decreased was regarded as the primary immune function lowlihead of erythrocyte, the rosette ratios of E-C 3 bR declined but the E-IC increased was tmicella (Jiang and Bai, 2007) . The present study showed endosulfan significantly decreased the rosette ratios of E-C 3 bR and improved E-IC in mice. The results suggested endosulfan led to the secondary immune function lowlihead of erythrocyte in mice. The CR1 had no distribution on erythrocyte membrane in mice (Jacobson and Weis, 2008) , but there was a kind of membrane protein which was related to CR1 function was called complement receptor I-related gene/protein (Crry) in mice, and widely expressed on tissue cell surface of mice. This protein was even more resembled CR1 in human (Li et al., 1993) . The analysis of sequence homology to CR1 gene in human showed the CR1 gene came from the evolution of Crry gene in rodent, and the two genes were alike in sequence and function, and the only difference was that the molecular weight of Crry protein was smaller than that of CR1 protein in human (Fletcher Control Endosulfantreated group
Experimental group
Concentration of CD58 on RBC (pg/ml) Fig. 4 . Effects of vitamin E on the protein expressions of immune correlation receptors of blood cell in endosulfan-treated mice (Mean ± S.E.). Asterisks represents significant differences (* = p < 0.05, ** = p < 0.01 and *** = p < 0.001). A: The changes of CD59 protein expressions; B: The changes of CD35 protein expressions; C: The changes of CD58 protein expressions. al., 1994) , and the CR1 protein in human included many functional domain of Crry protein (Holguin et al., 1990) . So the immune adherence function of erythrocyte in mice might realize through Crry protein. The present study showed that there was no the expression of CR1 on erythrocyte membrane, while the expression of CR1 on lymphocyte membrane surface significantly decreased in mice. Because erythrocyte had no nucleolus in mice and spleen is a hemopoiesis organ and blood reservoir, so the CR1 mRNA levels of spleen were determined. The results showed that endosulfan obviously declined the CR1 mRNA levels of spleen, which is the same as the protein expression change of CR1 on B lymphocyte membrane surface; and the Crry mRNA level of spleen in endosulfan group were lower than that of control group in mice. Therefore the reason of endosulfan led to the secondary immune function lowlihead of erythrocyte in mice could be endosulfan inhibited the expression of Crry gene, and decreased Crry protein quantity on erythrocyte membrane surface, and thereby lead to the decrease of E-C 3 bR rosette ratio. The decrease of Crry expression resulted in complement activation redundancy, and so caused pathologic lesion, while the increase of Crry expression by using Crry recombination or Crry transgenic technology can inhibite the damage caused by complement activation redundancy (Davoust et al., 1999) . Crry was necessary for rodent to protect organism from spontaneous damage of complement (Miwa et al., 2002) . Thereby the immune adherence function of erythrocyte in rodent might be recognized by Crry protein.
In addition, a protein on the platelet that resembled serum H factor could regulate complement in mice, and this protein was of part function of human CR1 cleaning immune complex, but it didn't distribute on erythrocyte membrane in mice. So the function of cleaning immune complex in mice was regarded as depending on platelet but not erythrocyte (Repik et al., 2005) . But the reports from Yin et al. (2007) showed erythrocyte from rodent
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The level of hydroxyl free radical (U/mg protein) could adhere the yeast fungus sensitized by complement and the yeast fungus non-sensitized. The present study also showed erythrocyte is of immune adherence function, and endosulfan decreased the mRNA levels of spleen H factor in mice. So we speculate that endosulfan decreased immune adherence activity of erythrocyte in mice through depressing the expressions of Crry and H factor.
The effect of endosulfan on the activities of erythrocyte immune adherence enhancing factor and immunosuppressive factor of plasm in mice The erythrocyte immune adherence enhancing factor in plasm was a thermoresistance factor, and it was not deactivation at 58°C for 30 min (Guo et al., 1988) , while immunosuppressive factor in plasm was a thermolabile glucoprotein, which was of inhibitory effects on erythrocyte immune adherence, and it was deactivation at 58°C for 30 min (Guo and Zhang, 1987) . The activity of enhancing factor was significantly higher than that of inhibitory factor under physiological condition (Guo et al., 1988) . Hypoxia declined the activity of enhancing factor but increased the activity of inhibitory factor (Li et al., 2009 ). The present results showed that 0.8 mg/(kg/d) endosulfan significantly depressed the activity of enhancing factor in plasm, while had no significant effect on the activity of inhibitory factor though it had an increase tendency. Our previously results showed that endosulfan decreased the activity of enhancing factor; while it inhibited the activity of inhibitory factor in low dosage and improved it in high dosage in plasm of mice (Zhang and Zhou, 2010) . The results indicated that the effect of endosulfan on the activity of inhibitory factor was complex, and its mechanism need to be investigated farther. The inhibitory factor of erythrocyte immune adherence could bind to IC regulated by C 3 b, and then blocked the C 3 b of IC so as to prevent C 3 bR from adherence IC, and thereby decreased the ability of erythrocyte cleaning IC (Fu and Wang, 2005) .
The effects of endosulfan on the regulation of NK cell and T cell activities by erythrocyte and its correlation factors in mice
Non-impaired erythrocyte obviously improved the cytotoxicity of NK cell antagonizing tumor cell. The enhancement effect of NK cell activity by erythrocyte was highest when the concentration ratio of NK cell and erythrocyte was 1: 50 (Shau and Golub, 1988) . The enhancement effect of NK cell activity induced by erythrocyte was caused by natural killer enhancing factor (NKEF) in erythrocyte kytoplasm widespread (Shau et al., 1993) . NKEF is not only significant enhancement effect to NK cell, but also played important roles in protecting main protein and DNA against oxidation damage (Wang and Guo, 1999) . That erythrocyte enhanced the cell poison effect of NK cell occurred in the short-time after NK cell binding target cell and before releasing NKCF (Cao and Du, 1990 ). But it is not clear at present what make erythrocyte release NKEF or enhance the expression of NKEF on membrane surface. The present results showed that 0.8 mg/(kg/d) endosulfan had no obvious effects on regulation of NK cell activity by erythrocyte. This results was similar to our previous study results (Zhang and Zhou, 2010) . Till now few report is available about the regulation of NK cell activity by erythrocyte, and its mechanism need to be investigated further. Arosa et al. (2004) reported erythrocyte was an activity modulator of T lymphocyte, and it promoted the survival of T lymphocyte in human peripheral blood and inhibited cell death and oxidative stress caused by its activation. The regulation action of human erythrocyte to the activity of T lymphocyte immune adhering tumor cell mostly performed by the interaction of both lymphocyte function associated antigen-3 (LAF-3/CD58) on the erythrocyte membrane and CD2 on the T lymphocyte, and boosted the tumor cells which have been regulated by lymphocyte immune adherence complement to form rosette. The present results showed that endosulfan had no effect on the regulation of T lymphocyte immune adherence activity by erythrocyte, although it led to a decrease tendency; endosulfan had also no significant effect on expressions of CD59 and CD58 protein of erythrocyte membrane surface and the mRNA level of spleen CD59 in mice; which could be because that endosulfan dosages used in present experiment was not enough to influence the regulation of T lymphocyte immune adherence activity by erythrocyte. High dosage endosulfan (6.4 mg/kg/d) obviously depressed the regulation activity of T lymphocyte immune adherence cancer cell by erythrocyte in mice (Zhang and Zhou, 2010) . Both CD59 and CD58 directly participated in the adhesive action of human T lymphocyte and CD59+CHO transfection soma, and the simultaneous expression rosette rates of both CD58 and CD59 transfection soma were markedly higher than the rosette rate of one of them, which indicated they two were of synergistic effect in mediating T lymphocyte immune adherence (Deckert et al., 1992) .
The effect of endosulfan on the oxidative stress of spleen in mice
The present study showed endosulfan significantly declined the T-AOC, and increased the MDA level and the producing ability of hydroxy radical of spleen in mice. The results suggested that endosulfan led to oxidative stress in mice. Endosulfan inhibited the activity of glutathion peroxidase and T-AOC in rat (Omurtag et al., 2008) ; caused DNA damage in both ovary cell of murine and human lymphocyte (Bajpayee et al., 2006) . Endosulfan could lead to the change of cellular membrane structure by oxidative stress, and therefore induced the changes of distribution of receptor on the erythrocyte membrane, and so affected the recognization and conjugation of erythrocyte to its target cell or antigen. In addition, oxidative stress could lead to the damage of DNA, and then influence the transcription and expression of erythrocyte immune correlation factor, and thus affected the regulation action of the factor to erythrocyte, and thereby decrease the erythrocyte immunocompetence.
The effects of Vitamin E on immune activity of erythrocyte in endosulfan-treated mice
Vitamin E was an important immunoenhancer. Vitamin E obviously increased the activity of NK cell in rat (Moriguchi et al., 1990) ; relieved the decreases of spleen NK cell activity and lymphocyte transformation caused by TCDD in mice ). The present study showed Vitamin E 100 mg/(kg/d) reversed the decrease of E-C 3 b RR rosette ratio, and antagonized the increase of E-IC rosette ratio caused by endosulfan, and relieved the decrease tendency of the regulation of T cell immune adherence activity by erythrocyte induced to exposure endosulfan, and reversed the activity decrease of immunoenhancement factor and the increase tendency of inhibiting factor activity caused by endosulfan in mice. The results suggested that Vitamin E relieved or partly relieved the decrease of erythrocyte immune function induced by endosulfan. This could be because that Vitamin E could effectively declined the lipid peroxidatic reaction caused by endosulfan, and protect cell membrane from the attack of free radicle, and therefore maintain the integrity of erythrocyte membrane structure and the stableness of distribution in receptor on its membrane, and relieved the decrease of erythrocyte immune function induced by endosulfan. The present study showed Vitamin E 100 mg/kg reversed the decrease of spleen T-AOC, and depressed the increases of MDA and hydroxy radical induced by endosulfan in mice. Vitamin E stabilized membrane fluidity through preventing spontaneous oxidization of lecithoid unsaturation acyl group chain in cell membrane during lymphocyte proliferation (Fountain et al., 1982) . The absence of Vitamin E declined the activities of GSH-Px and SOD in lymphocyte, and improved the level of MDA and membrane permeability, and decreased the membrane fluidity in lymphocyte in chicken (Wang et al., 2007) . In addition, Vitamin E probably maintained the normal transcription and expression of erythrocyte immune correlation factor through preventing oxidative stress from DNA damage, and therefore relieved the decrease of erythrocyte immune function induced by endosulfan. The present study showed Vitamin E reversed the decreases of CR1 mRNA and Crry mRNA level, and partly relieved the decrease H factor mRNA level in spleen in endosulfan-treated mice. The results suggested that Vitamin E relieved the changes of genetic transcription and expression of immune correlation factors in endosulfan-treated mice. Vitamin E not only let to the increase of antioxidase activity, but also depressed the damages of the DNA and alkylation induced by oxidative stress through boosting the capability of cleaning free radical (Georgiadis et al., 2000) .
In summary, Vitamin E relieved endosulfan-induced the decrease of erythrocytes immunity, reversed changes in genetic transcription\expression of erythrocyte immune factors, and antagonized oxidative stress. Vitamin E could stabilize the distribution and expression of erythrocyte immune correlation factor by inhibiting oxidative stress caused by endosulfan, and thereby reverse the decrease of erythrocyte immunocompetence caused by endosulfan.
